XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue:        
Total revenue $ 9,390,388 $ 8,810,847 $ 29,071,316 $ 27,681,164
Cost of revenue 4,108,773 3,203,981 10,716,394 10,600,421
Gross profit 5,281,615 5,606,866 18,354,922 17,080,743
Other expenses:        
Research and development 1,851,230 3,749,197 5,619,040 11,632,416
Legal, financial and other consulting 823,914 1,103,475 2,325,351 2,957,738
Selling, general and administrative 7,002,718 8,104,392 23,151,118 24,358,417
Total expenses 9,677,862 12,957,064 31,095,509 38,948,571
Loss from operations (4,396,247) (7,350,198) (12,740,587) (21,867,828)
Other income (expense):        
Interest expense, net (588,153) (33,670) (774,903) (105,662)
Gain (loss) on foreign currency transactions 2,650,309 (1,809,652) 680,392 (733,997)
Miscellaneous income       35,000
Total other income (expense), net 2,062,156 (1,843,322) (94,511) (804,659)
Loss before benefit from income taxes (2,334,091) (9,193,520) (12,835,098) (22,672,487)
Benefit from income taxes 0 0 0 0
Net loss attributable to common stockholders $ (2,334,091) $ (9,193,520) $ (12,835,098) $ (22,672,487)
Basic net loss per common share $ (0.04) $ (0.21) $ (0.24) $ (0.52)
Diluted net loss per common share $ (0.04) $ (0.21) $ (0.24) $ (0.52)
Weighted average number of shares of common stock outstanding, basic 54,453,006 44,373,969 54,340,583 44,024,483
Weighted average number of shares of common stock outstanding, diluted 54,453,006 44,373,969 54,340,583 44,024,483
Comprehensive loss:        
Net loss $ (2,334,091) $ (9,193,520) $ (12,835,098) $ (22,672,487)
Other comprehensive income (loss):        
Foreign currency translation adjustment (2,330,743) 1,655,674 (686,246) 654,792
Comprehensive loss (4,664,834) (7,537,846) (13,521,344) (22,017,695)
Total product sales        
Revenue:        
Total revenue 8,612,795 7,754,016 26,444,104 23,736,468
CytoSorb sales        
Revenue:        
Total revenue 8,586,274 7,709,085 26,381,455 23,681,183
Other product sales        
Revenue:        
Total revenue 26,521 44,931 62,649 55,285
Grant income        
Revenue:        
Total revenue $ 777,593 $ 1,056,831 $ 2,627,212 $ 3,944,696